While prior studies have documented persistent IL-6 elevation and its cardiovascular implications in psoriasis (29, 30), our study adds novel insight by highlighting the combined effect of visceral adiposity and residual cytokine activity on IL-6 across different treatment modalities. This evidence concerns the gene IL6 and psoriasis.